The nanomedicine group originated from the laboratory of Dr. Alexander ("Sasha") Kabanov at the UNMC Department of Pharmaceutical Sciences in 1994. The first trainees of this laboratory, Dr. Serguei Vinogradov, Dr. Tatiana Bronich and Dr. Elena Batrakova, subsequently assumed faculty positions in the department. Dr. Joe Vetro joined the department in 2004 as a new faculty recruit. These individuals went on to lead independent research projects and actively collaborated to support a joint nanomedicine group seminar to foster creative environment, exchange of ideas, and interdisciplinary education of students and postdoctoral scientists.  This group evolved into the Center for Drug Delivery and Nanomedicine (CDDN) and the associated COBRE Nebraska Center for Nanomedicine (NCN), with Dr. Kabanov serving both as Director.  Following Dr. Kabanov's departure for a new position at the University of North Carolina at Chapel Hill, Dr. Tatiana Bronich has taken on leadership of the Nanomedicine group as well as Directorship of the NCN, and continues to serve as CDDN Associate Director while a recruitment search is underway for the CDDN's new Director.